Amgen Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 31, 2025: USD 5.58 B

Amgen Inc. Depreciation And Amortization is USD 5.58 B for the Trailing 12 Months (TTM) ending March 31, 2025, a 22.10% change year over year. Depreciation and amortization are expense that reduces the value of tangible and intangible assets over their useful lives for tax and reporting purposes.
  • Amgen Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 4.57 B, a 31.47% change year over year.
  • Amgen Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 3.48 B, a 2.30% change year over year.
  • Amgen Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 3.40 B, a -4.15% change year over year.
  • Amgen Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 3.54 B, a 35.93% change year over year.
Key Data
Date Depreciation And Amortization Dividends Paid Common Stock Issued Common Stock Repurchased